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Abstract Salivary levels of biomarkers for the hypothalamic–
pituitary–adrenal axis (HPA; cortisol) and sympatho-adreno-
medullary system (SAM; α-amylase) were measured in 51
adults (57% male) with neurodevelopmental disorders associ-
ated with intellectual disability (i.e., mental retardation) and
chronic self-injurious behavior (SIB) and compared with
matched controls without SIB. Cortisol levels differed signif-
icantly (p<0.01) between the SIB and control group (SIB>
control). Within-group analyses showed significant differences
(p<0.05) in levels of salivary α-amylase between individuals
with SIB and those with SIB meeting criteria for stereotyped
movement disorder (SMD; SIB+SMD>SIB). Salivary α-
amylase was significantly correlated with frequency of
stereotypy among the SIB group (r=0.36, p<0.05). These
preliminary findings warrant further exploration into the role
of the SAM system in the pathophysiology of SIB and related
repetitive behaviors among individuals with neurodevelop-
mental disorders associated with intellectual disability.
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Self-injuriousbehavior(SIB)isarelativelyprevalentbehavior
disorder among populations of people with neurodevelop-
mental disorders associated with intellectual and develop-
mental disabilities (IDD), with estimated prevalence rates
between 5–20% of persons with IDD engaging in SIB
(Schroeder et al. 2001). The presentation of SIB can be
severe, characterized by non-accidental and self-inflicted
head-banging, body-hitting, eye-gouging, self-biting, hair-
pulling, and other activities causing injury. The pathophys-
iology of SIB is poorly understood, and consequentially, the
disorder can be difficult to treat effectively. There are no
standard first choice pharmacological treatments for SIB,
making the clinician’s judgement the primary determinant of
treatment (Osman and Loschen 1992). Limited research on
biological mechanisms and their markers has impeded the
identification of specific and effective forms of psychophar-
macological treatment (but see Sandman et al. 1999). The
study of biological markers, therefore, may be especially
useful in aiding diagnosis, treatment course decisions, and in
gaining a greater understanding of SIB pathophysiology.
Studies of biological markers among individuals with
SIB and IDD have demonstrated a relationship between
SIB and stress, which has mostly been focused around the
hypothalamic–pituitary–adrenal (HPA) axis. After a SIB
episode, plasma β-endorphin levels increase and uncouple
from adrenocorticotropic hormone (ACTH; Sandman et al.
1997; Sandman et al. 2003). Under normal circumstances,
ACTH and β-endorphin levels are highly correlated, as they
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DOI 10.1007/s11689-011-9080-9are both derived from the parent peptide proopiomelanocortin
(Guillemin et al. 1977). In addition, individuals with IDD
exhibiting SIB have also been found to have elevated saliva
cortisol levels, and cortisol levels were correlated with SIB
severity (Symons et al. 2003). Both the β-endorphin-ACTH
uncoupling and altered cortisol levels among individuals
with IDD and SIB suggest that the HPA stress axis is altered
in individuals with IDD exhibiting SIB (Sandman et al.
1997; Sandman et al. 2003; Symons et al. 2003). It is
unlikely that these alterations in the stress response are
generalizable to all persons exhibiting SIB. For example, not
all individuals have increases in β-endorphin levels after
self-injury (Sandman et al. 1997; Sandman et al. 2003).
There is also a great deal of comorbidity among individuals
with IDD with SIB and stereotypic motor behavior. The co-
expression of stereotypy and SIB is estimated at upwards of
50% in children and adults with intellectual disability (Bodfish
et al. 1995; Rojahn 1986). Epidemiological studies have
shown a strong association between SIB and various
stereotypic behaviors among individuals with IDD (Rojahn
1986). These findings suggest individuals who express SIB
and stereotypy may fall into a different category of abnormal
behavior than those with SIB only or stereotypy only.
Although specific biochemical abnormalities have yet to be
demonstrated among these subtypes, Hessl et al. (2008)
showed genotype differences in the serotonin transporter
(5-HTTLPR) for stereotypy [LL>SL, SS]) in a sample of
individuals with fragile X syndrome.
Pharmacological evidence also supports indirectly the
possibility of separate subgroups of individuals with both SIB
and stereotypy. For example, individuals with IDD with both
stereotypy and SIB react differently to sedative–hypnotics than
persons with only SIB, only stereotypy, or neither behavior
disorder. In this sample, individuals with both SIB and
stereotypy were most likely to respond to large doses of
sedative–hypnotics by “maintaining wakefulness, and produc-
ing either resistive, combative, restless, uncooperative, or
abusive behaviour” (Barron and Sandman 1983). In another
study, increased opiate sensitivity in SIB skin pickers with
stereotypy was found, when compared with patients with
trichotillomania, a less severe form of stereotypy (Frecska and
Arato 2002). Together, pharmacological and epidemiological
investigations suggest that SIB in individuals with pathologic
(i.e., based on Diagnostic and Statistical Manual on Mental
Disorders, Fourth Edition (DSM-IV) criteria) stereotypic
behavior may exist as a subgroup or possibly separate
behavioral phenotype with a unique biological profile.
A separate stress system which has received almost no
attention in humans in the study of stereotypy and SIB is the
sympatho-adreno-medullary (SAM) system. In animal models,
sympathetically dominated pigs, when tethered over long-term,
develop stereotypies and increased sympathetic tone. Stereo-
typic behavior was found to decrease heart rate in these animals
and counteract the overactive sympathetic tone (Schouten and
Wiegant 1997). Heart rate monitoring in rhesus monkeys has
shown that SIB monkeys experience an increase in heart rate
before a bout of self-injury and that self-biting returns heart
rate back to basal levels (Novak 2003). In humans, evidence
for altered SAM response in SIB and stereotypy has been
mostly pharmacological. Although no placebo-controlled
double-blind clinical trials have been performed, a number
of studies have documented efficacy of adrenergic attenuating
drugs such as clonidine and propranolol in the treatment of
SIB (Blew et al. 1999; Luchins and Dojka 1989; Philipsen et
al. 2004;R u e d r i c he ta l .1990; Symons et al. 2004). These
findings suggest that stereotypic behaviors and SIB may be
elicited in situations of SAM over-reactivity.
Given the evidence summarized briefly above, the
overall goal of our work was to extend the study of
biomarkers in SIB research among individuals with IDD.
We examined two specific stress-related biomarkers based,
in part, on the findings from other independent research
groups in areas of stress physiology relevant to the problem
of SIB in individuals with IDD. Because this is a highly
vulnerable population with cognitive and communicative
impairments, we adopted a noninvasive approach based on
collecting and assaying saliva. Salivary assessment pro-
vides a noninvasive means of examining biological aspects
of and stress-related HPA/SAM activity in routine clinical
settings (Hellhammer et al. 2009).
Our general strategy involved first collecting saliva on
matched (gender, age, developmental level) individuals with
IDD, with and without SIB, for initial comparisons. Then,
within-SIB subgroup comparisons were made based on the
presence/absence of stereotyped behavior. We tested the
hypothesis that individuals with chronic SIB would display
altered basal stress-related biochemical markers. As a marker
of HPA axis function, we measured salivary cortisol levels
(Stahl and Dorner 1982). We measured salivary α-amylase
enzyme activity as a marker of SAM axis function
(Chatterton et al. 1996; Nater et al. 2005;R o h l e d e re ta l .
2004; van Stegeren et al. 2006).
Method
Participants
Individuals were recruited from the total residential population
(N=366) of a regional center for adults with intellectual and
associated neurodevelopmental disorders and related disabil-
ities. From the subgroup of residents with chart diagnoses that
included self-injury (n=98), a sample of 51 adults (57%
male) with intellectual and developmental disabilities partic-
ipated in this study (SIB group, n=34; no SIB control group,
n=17). Control participants were matched on chronological
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(exact match based on DSM-IV levels—mild, moderate,
severe, or profound), and gender (exact match). The mean
age was 48.4 years (range, 20–65 years) for the SIB group
and 43.8 years (range, 30–65 years) for the control group.
Males comprised 62% of the SIB group and 47% of the
control group; 8% of the sample functioned in the moderate
range of mental retardation; 10% of the sample functioned in
the severe range of mental retardation, and 82% of the
sample functioned in the profound range of mental retarda-
tion. Chi-square tests showed no significant differences in
the demographic (age, IQ, gender) characteristics of SIB and
non-SIB groups. Participants resided in a residential facility
providing services for individuals with complex behavioral
and/or medical needs.
Inclusion/exclusion criteria The following criteria were
used to select non-SIB participants (male or female).
Inclusion: (1) have a diagnosis of severe/profound or
moderate intellectual disability (based on DSM-IV criteria
and standard intellectual and adaptive behavioral test results
within the previous 3 years as documented through existing
chart review); (2) be between the ages of 18–65 years.
Exclusion: (1) serious accompanying chronic health impair-
ments that are considered to be painful (e.g., chronic reflux
or otitis media as determined by subjects’ physician record
review and/or examination if necessary).
The following criteria were used to select SIB partic-
ipants (male or female): Inclusion: (1) have a diagnosis of
severe/profound or moderate intellectual disability (based
on DSM-IV criteria and standard intellectual and adaptive
behavioral test results within the previous 3 years as
documented through existing chart review); (2) be between
the ages of 18–65 years; (3) exhibits SIB either hourly or at
least daily in bouts or discrete episodes (based on staff
report using the Behavior Problems Inventory (Rojahn et al.
2001); (4) persistent SIB (present for at least the last
12 months; based on staff report/behavioral incidents in
records); (5) receiving treatment for SIB that is currently
stable (not planned on being changed in the next month);
(6) parent or guardian informed consent. Exclusion: (1)
serious accompanying chronic health impairments that are
considered to be painful (e.g., chronic reflux or otitis as
determined by subjects’ physician record review and/or
examination if necessary) or (2) specific syndromes known
to be associated with SIB (e.g., Lesch–Nyan syndrome,
Cornelia de Lange syndrome).
Saliva collection and processing
One milliliter of unstimulated saliva was collected in the
early afternoon (approximately 2:00PM [mean=1:44PM,
SD=36 min] with one exception for one participant
collected at 10:00AM: collection times did not differ
significantly by group [SIB vs control]). Participants
received no food, liquid, or tooth brushing nor did they
display self-injurious behaviors within the hour prior to
collection. Each residential living unit had in place a
standard surveillance system for monitoring severe behav-
ior disorders including SIB. Research staff were present
for the 1 h prior to the collection time to corroborate the
absence of SIB. Collection days were randomly chosen
across participants (with some breakdown in this given
idiosyncratic changes in individual participant’sd a i l y
schedule). Saliva was collected by swabbing the individ-
ual's mouth using Toothettes. Toothettes were cut and
placed into Salivette tubes and centrifuged at 3,000 rpm
for 5 min. For each individual, the resultant saliva from
each Toothette was then mixed together using a Vortex for
45 s at a speed of 1,820 RPM, aliquoted into labeled
microtubes, and stored at −80 C until used.
Assays
Group membership was blinded prior to conducting assays.
On the day of the assay, samples were thawed and vortexed.
Freeze–thaw cycles were minimized.
Cortisol Cortisol levels where measured by enzyme immuno-
assay using a commercially available colorimetric kit according
to the manufacturer’s instructions (Salimetrics, State College,
PA; Catalog # I-3012). Colorimetric determination was
performed on a SpectraMax M2e plate reader (Molecular
Devices, Sunnyvale, CA). The assay has a calibration range
0.12–30 ng/ml with a sensitivity of 0.03 ng/ml. All measure-
ments were performed in triplicate and averaged.
Salivary α-amylase Salivary α-amylase was measured
using a commercially available enzyme reaction assay
according to the manufacturer’s instructions (Salimetrics,
State College, PA; Catalog # 1–1902). The kinetic
formation of cleaved 2-chloro-p-nitrophenol from 2-chloro-
p-nitrophenol-linked maltotriose by salivary α-amylase
was spectrophotometrically measured at 405 nm and by
colorimetry using a SpectraMax M2e plate reader (Molecular
Devices, Sunnyvale, CA). The amount of salivary α-amylase
activity present in the sample is directly proportional to the
increase in absorbance at 405 nm. All measurements were
performed in triplicate.
Analyses and statistics
A matched between-groups design was used. Descriptive
statistics were used to characterize measures of central
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across and within groups. Parametric (when appropriate) and
nonparametric statistics were used to compare biomarkers
across groups. Analyses were performed with and without
outliers (beyond 2 SDs from the mean). Correlational and
additional comparative analyses were used to examine
relations between demographic, procedural, and individual
characteristics and biomarkers within the SIB group.
Results
Correlations and categorical variable comparisons
A number of demographic (age, gender, intellectual
disability level), procedural (time of day of collection),
and SIB (reported frequency) variables were examined to
determine whether they were associated with the biomarker
variables. Alpha-amylase differed significantly by level of
intellectual impairment across groups when tested using the
Kruskal–Wallis at χ
2 (2)=8.15, p=0.017 (Table 1). Total
stereotypy, when measured by the Behavior Problems
Inventory (regardless of stereotypic movement disorder
[SMD] diagnosis; see below), was significantly correlated
with α-amylase (r=0.36, p<0.05) among all participants
with SIB and stereotypy (n=34). With the removal of two
outliers, α-amylase was strongly correlated with total
stereotypy (r=0.57, p<0.001; Fig 1). Cortisol and salivary
α-amylase were non-significantly negatively correlated in
this sample for SIB only cases (r=−0.22) and for SIB+
SMD cases (r=−0.22).
Between-group comparisons (SIB vs no SIB)
We compared all SIB cases with the no SIB cases. Levene’s
test statistics indicated borderline or significant homogene-
ity of variance for most groups. As such, the nonparametric
Mann–Whitney U test was employed to test differences for
salivaryconcentrationsofα-amylaseand cortisol.Descriptive
and Mann–Whitney U test statistics and results are presented
in Table 2. Significant differences between groups (SIB vs.
no SIB) were detected for cortisol.
Between-group comparisons (SIB subgroups)
SIB vs SIB+SMD vs control Initial data analysis indicated
adequate normality and homogeneity (using Levene’s test)
for about half of the variables for the comparison of the
biomarkers across a SIB-only group, a SIB group that met
DSM-IV diagnostic criteria for SMD and the no SIB
controls. Analysis of variance was employed to test differ-
ences for salivary concentrations of each biomarker across
these three groups. No significant group differences were
detected for this parametric comparison. Because homoge-
neity was borderline for the biomarkers (~50%), the
nonparametric Kruskal–Wallis test was employed. Results
of this test are presented in Table 3. Significant differences
across groups were indicated for α-amylase and cortisol. A
further comparison was made specific to individuals with
SIB comparing SIB only and SIB+SMD. A significant
difference was detected between groups for the biomarker
α-amylase with U=69, z=−2.59, p=0.009.
Discussion
SIB among adults with severe IDD represents a serious
problem occurring in up to 20% of system-wide surveys
and clinical samples. Very little is known about the
pathophysiological mechanisms underlying SIB; a long-
Table 1 Descriptive and Kruskal–Wallis results for level of intellec-
tual impairment subgroups
Variable Moderate Severe Profound χ
2 (df) p
Value
α-Amylase 8.15(2) 0.017
n 45 4 2
M (SD) 32.8 (22.8) 166.1 (99.5) 117.9 (97.2)
CV 1.44 1.67 1.21
Cortisol 2.49(2) 0.288
n 45 4 2
M (SD) 18.5 (32.5) 1.3 (1.6) 3.17 (9.8)
CV 0.57 0.81 0.32
Fig. 1 Scatter plot of salivary α-amylase and total stereotypy based
on the Behavior Problems Inventory among participants with SIB
(n=32, r=0.571, p<0.001)
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and arousal play a role in the expression of the behavior.
Limited work suggests an association between SIB and the
HPA axis, but findings are mixed in this regard (Kemp et al.
2008; Sandman et al. 1990; Symons et al. 2003; Verhoeven
et al. 1999). No work has specifically examined the SAM
system although there is an apparent association between
this system and SIB/stereotypy in non-human primate
research as well as pharmacological work specific to
adrenergic medications (Blew et al. 1999; Novak 2003;
Philipsen et al. 2004; Symons et al. 2004; Tiefenbacher et
al. 2000). The goal of this preliminary study was to
noninvasively examine the HPA axis and SAM systems
by testing two salivary biomarkers for each system, cortisol
and α-amylase, respectively.
Overall, individuals with SIB had elevated levels of
cortisol compared with matched individuals (age, gender,
level of intellectual impairment) who did not self-injure.
Our current results replicate previous findings of elevated
cortisol among those with chronic SIB (Symons et al. 2003;
Verhoeven et al. 1999). Among the SIB group, there were
significant differences in salivary α-amylase levels between
individuals with and without a co-occurring SMD. The
observed elevated levels of α-amylase associated with
chronic SIB and stereotyped behavior as well as a positive
correlation with severity of IDD are novel findings and may
indicate altered sympathetic activity. Given that the findings
were specific to a subgroup of individuals with SIB, it
suggests that future work should attend to co-morbid
conditions (e.g., stereotypy) occurring among individuals
with SIB. Frecska and Arato (2002) showed that individ-
uals with SMD and SIB in the form of skin-picking differed
significantly on an opioid sensitivity test than a comparable
group with less serious forms of SIB (hair-pulling). At the
risk of oversimplifying a complex disorder, such subgroup
differences logically support different therapeutic
approaches, although a clinical trial would be needed to
definitively test this logic.
There are several study-specific issues that limit the
generality of the study findings reported here. The sample
was not formed randomly, and therefore, the results are
specific to the individuals reported on herein. The sample
was residential and composed primarily of individuals with
significant intellectual disabilities, and therefore, it is not
clear how our findings would generalize to a more
heterogeneous and community-based intellectual disability
population. We did not directly measure environmental
variables (e.g., social density, staff interactions, etc.), and so
their possible effects are unknown, but future work may be
designed to consider their influence on the systems
underlying the two biomarkers we studied (cortisol, sAA).
We did, however, try to be clear about the sample formation
and composition to facilitate logical generalization to compa-
rable individuals with IDD. Although we were careful to
collect saliva from individuals under as standardized con-
ditions as possible with respect to time of day and
environmental events, factors of timing (in relation to
behavioral events) and decay may impact the usefulness and
measurement validity of saliva collection (see Hellhammer et
al. 2009 and Rohleder and Nater 2009, for excellent reviews
regarding methodological considerations concerning saliva).
Also, the single time-point for collection, although common
to all participants (thereby controlling for time of day)
provides a very limited window into the activity of either
system (HPA, SAM).
Given the limitations described above, we can only
speculate on what the differences in α-amylase means for
the SAM axis in these groups. It may be that there is
elevated sympathetic tone in people with both SIB and
stereotypy. Individuals with SIB plus SMD may respond to
stress and arousal in different ways than individuals with
SIB only. Among real-world tests of acute stress effects in
non-disabled study samples, stress-mediated (elevated) total
protein and α-amylase were found to be significantly
higher immediately preceding a stressful event (academic
test) than during non-stress times (2 and 6 weeks later)
among dental students (Bosch et al. 1996). In a single-case
Table 2 Descriptive and Mann–Whitney U test results for SIB and no
SIB subgroups
Variable SIB No SIB Z score U p Value
α-Amylase −0.66 319 .510
n 34 17
M (SD) 110.1 (79.3) 127.9 (126.9)
Cortisol −2.79 196 0.005
n 34 17
M (SD) 5.3 (15.1) 1.9 (5.1)
Table 3 Descriptive and Kruskal–Wallis results for SIB, SIB+SMD,
and control subgroups
Variable SIB SIB+SMD Control χ
2 (df) p
Value
α-
Amylase
7.68 (2) 0.021
n 18 16 17
M (SD) 88.1 (87.4) 134.7 (62.8) 127.9 (126.9)
CV 1.01 2.14 1.01
Cortisol 6.39 (2) 0.041
n 18 16 17
M (SD) 5.7 (16.1) 5.0 (14.4) 1.88 (5.12)
CV 0.35 0.35 0.37
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borderline personality disorder, Sachsse et al. (2002)
documented increasing nocturnal urinary cortisol levels
were associated with self-mutilation and that urinary
cortisol levels dropped following episode of SIB. Their
discussion focused on the possible relation between stress
and affect regulation in relation to self-injury. Whether
similar findings related to acute stressors or in relation to
acts of SIB would have similar effects among individuals
with IDD is an open question. Our results do provide one
possible mechanism for how clonidine or propranolol
would work to reduce SIB (Blew et al. 1999; Luchins and
Dojka 1989; Ruedrich et al. 1990; Symons et al. 2004).
There is the possibility that the SIB+SMD group would be
more reactive to propranolol/clonidine which, in turn, raises
the possibility that amylase could be used as a marker to
screen individuals who may be responsive to propranolol/
clonidine treatment.
In this work, we demonstrated biochemical differences
between control, SIB, and SIB+SMD groups, observable in
the saliva of persons with intellectual impairments associ-
ated with neurodevelopmental disorders, suggesting it may
be possible to use biomarkers to catalog and discriminate
different behavioral disorders. Although the ultimate func-
tional significance of bioactive peptides found in the human
major salivary glands remains an area of active research, it
is clear that chronic stress and related environmental effects
produce profound changes in various autonomic nervous
system functions both in animal models and in human
subjects (Hellhammer et al. 2009; Nater and Rohleder
2009; Rohleder et al. 2004). It is therefore possible that
these changes are reproduced in many parts of the
autonomic nervous system, including those supplying
human salivary glands. Thus, the characteristic pattern of
activity should be reflected in changes in the concentration
ratios of selected neuropeptides in the saliva.
To this point—characteristic patterns of activity—the
work reported here raises additional issues specific to
assumptions underlying our approach (and much of the
conventional wisdom) to biomarker work among vulnerable
clinical populations with compromised intellectual and
communicative abilities. If the level of a putative stress
biomarker is elevated, this is taken as evidence of elevated
stress or stress-related activation. Absent an independent
and specific stress test, such conclusions are rarely
warranted. Raised levels of cortisol, for example, may
reflect down-regulated glucocorticoid receptors (GR). A
key difference may be whether the effects are related to
acute or chronic activation—different mechanisms may
become more or less relevant (for example, the relative
degree of interplay between corticotrophin-releasing factor
neurons, adrenocorticotrophic hormone (ACTH), and sym-
pathetic activation contribute considerable covariation in
salivary cortisol levels). More generally, the notion of
inferring simple linear effects (‘high cortisol’=high stress) is
not tenable—salivary cortisol levels vary considerably with
respect to adrenal capacity, liver metabolism, cortisol binding
globuline, and GR gene variants (Hellhammer et al. 2009).
Given our preliminary observations about differences in two
stress-related markers, there are two specific areas that
warrant additional attention, the first is our understanding
of whether different subgroups with SIB and stereotypy
represent different pathways to a disorder and the second is
our understanding of stress and sympathetic/parasympathetic
response and regulation.
With respect to the former—different subgroups—motor
stereotypy has been associated with striatal morphology
and function, with striatal dopamine in particular positively
associated with elevated stereotypy (Aliane et al. 2011;
Hollander et al. 2005). Frontal–striatal dopamine pathways
have likewise been implicated in the learning and mainte-
nance of repetitive behaviors in general (Graybiel 2008).
Lower sAA among the SIB group may indicate reduced
output of norepinepherine, suggesting diminished upstream
dopaminergic function. It may be that motor stereotypy is
distinct from repetitive self-injury with regard to its neural
underpinnings. For those with both SIB and SMD,
stereotypy may have a moderating influence on striatal
dopamine and ACTH function. Dampened sAA among
those with SIB alone may reflect circuit-level changes
resulting from prolonged dopamine release associated with
self-injury, consistent with an addiction model of SIB
(Graybiels 2008; Sandman et al. 1999). Hypodopaminergic
function within the striatum has been previously associated
with self-injury among persons with Lesch–Nyhan syndrome
(Wong et al. 1996). Alternatively, the findings may reflect
distinct SIB pathogenesis with regard to neurocircuitry. What
both SIB groups (those with and without SMD) share in
common was elevated cortisol, which indicates higher basal
arousal relative to controls. While it is possible that stress
and stress responsivity play a role in the production of
repetitive behavior, it is difficult to discern the direction of
the stress–behavior relationship with biomarker data alone
(Major et al. 2009).
With regard to the last point made above—stress response/
regulation—the general approach has been to interpret
elevated markers in the framework of normal physiologic
response to stress (see Moghaddam 2002 for an extended
discussion). It may be, however, that the stress response itself
is abnormal and that we have yet to work out how the
vulnerabilities created by the different neural insults that
ultimately lead to intellectual disability regulate the different
neural stress axes. In other words, we are not yet well
positioned to know whether our observations reflect normal
or abnormal stress physiology (i.e., the system is working in
overdrive vs the system is working differently).
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population, collection of salivary samples is a practical and
noninvasive means of obtaining data pertaining to bio-
markers for HPA axis (cortisol) and SAM system activity
(α-amylase) among individuals with significant IDD. The
observed elevated levels of α-amylase associated with
chronic SIB and stereotyped behavior as well as a positive
correlation with severity of IDD are novel findings and may
indicate altered sympathetic activity. These preliminary
findings warrant further exploration into the role of the
SAM system in the pathophysiology of SIB and related
repetitive behaviors among individuals with intellectual
disabilities and neurodevelopmental disorders.
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